Skip to content

Profound Medical PROF US — Total Assets

Other geography segments

CA
$61.45M+23.1%
FI
$3.35M+21.4%
DE
$1.16M-36.3%
CN
$108K-6.1%

Similar metrics at other companies

Climb Global Solutions, Inc. logo
CLMBUS — Total Assets
$281.66M+27.2%
PTC Therapeutics logo
PTCTUS — Total Assets
$2.53B+88.0%
FTE
FTEKUS — Total Assets
$41.75M-2.4%
Innospec logo
IOSPUS — Total Assets
$555.9M-6.4%
Upbound Group, Inc. logo
UPBDUnited States — Total Assets
$3.21B+23.5%
International Tower Hill Mines logo
THMUS — Total Assets
$55.83M0.0%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's us — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's US — total assets?
Profound Medical (PROF) reported US — total assets of $7.39M in Q1 2026.
How has Profound Medical's US — total assets changed year-over-year?
Profound Medical's US — total assets increased by 18.0% year-over-year, from $6.27M to $7.39M.
What does US — total assets mean?
Reflects the total economic resources controlled by the company specifically attributed to its United States operations. It provides insight into the scale of the company's footprint and the capital intensity required to support its domestic commercial activities.